Navigation Links
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Date:9/10/2009

SOUTH PLAINFIELD, N.J., Sept. 10 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 3 trial of ataluren (formerly PTC124(R)), an investigational protein restoration therapy in patients with nonsense mutation cystic fibrosis (nmCF). Patients with CF lack adequate levels of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver, and other organs. In nmCF, an interruption in the genetic code -- known as a nonsense mutation -- prematurely halts the synthesis of CFTR, causing the protein to be short and non-functioning. Nonsense mutations are categorized as Class I mutations that result in little or no production of the CFTR protein. CF patients with Class I mutations typically experience more severe disease symptoms than those with low-risk genotypes, including a greater than twofold increased risk of death,(1) a higher probability of end-stage lung disease,(2) and a higher prevalence of pancreatic insufficiency.(2) Ataluren is designed to promote restoration of the missing CFTR. Through advances in genetic analysis, a simple test can now determine if a patient's disease is caused by a nonsense mutation.

(Logo:http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

The primary objective of the registration-directed double-blind, placebo-controlled study is to evaluate whether ataluren can improve lung function, as measured by forced expiratory volume in one second (FEV1), in patients with nmCF. Other outcome measures will evaluate whether ataluren can reduce symptoms associated with nmCF, decrease lung infections, reduce the frequency of cough, and improve patient-reported quality of life. The 48-week trial is now enrolling patients at multiple resea
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 Interventional cardiologist Tony Farah, MD, ... (AGH) Cardiovascular Institute have helped pioneer many breakthroughs ... (CAD) over the past three decades, from new ... and coronary artery stent implantation. , Today, AGH officials ... prominent role in the study of a novel, first-of-its ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today unveils a ... of hospital costs across the United States . The ... of “Medicare Provider Charge Data,” a dataset of pricing ... Centers for Medicare & Medicaid Services. , The wide ... the country has sparked considerable controversy; however, it is ...
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Kitware Enables Interactive Exploration of CMS Medicare Data 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... Sept. 24 Cyberonics, Inc. (Nasdaq: CYBX ) today ... JMP Securities 4th Annual Healthcare Focus Conference in New York on ... will host a webcast of the presentation live and by replay ... available for 90 days following the conference. Presentation slides will ...
... CAMBRIDGE, Mass., Sept. 24 Peptimmune, Inc. ("Peptimmune"), a ... a research and development collaboration with the Walter Reed Army ... (NMRC), Silver Spring, MD to evaluate the Company,s proprietary DEEP(TM) ... and point-of-care diagnostics. , , After ...
... YORK, Sept. 24 Reportlinker.com announces that a new market ... In Vitro Diagnostics in a ... , , http://www.reportlinker.com/p0119227/In-Vitro-Diagnostics-in-a-Recession-IVD-Market-Forecasts-Analysis-and-Success-Strategies.html ... commonly asserted that in vitro diagnostics is a recession-proof industry. ...
Cached Biology Technology:Cyberonics to Present at JMP Securities 4th Annual Healthcare Focus Conference 2Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 3Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 4Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 5Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 6Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 7Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 8Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 9
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2
... of the most devastating diseases in sub-Saharan Africa almost ... sickness, or trypanosomiasis, largely succumbed to heroic public health ... past several decades, because of post-colonial turmoil, the catastrophic ... the Democratic Republic of the Congo, the Sudan and ...
... annual migration time on Cape Cod again, the time of ... thousands. It's a sign of spring to the fishermen who ... here at the Marine Biological Laboratory (MBL), it triggers an ... world, who return here faithfully every summer to study the ...
... not only is vital to the immune system's ability to ... an unexpected location within the cell, causing researchers to rethink ... , Researchers at UT Southwestern Medical Center said their findings ... viral diseases such as the flu, hepatitis, West Nile virus ...
Cached Biology News:Compound might defeat African sleeping sickness, clinical trial beginning this month 2Compound might defeat African sleeping sickness, clinical trial beginning this month 3Compound might defeat African sleeping sickness, clinical trial beginning this month 4Gifts from the sea 2Gifts from the sea 3New protein vital for immune response is found in surprise location 2New protein vital for immune response is found in surprise location 3
Request Info...
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* Cell Biology Imaging Tools and Accessories Microscope Slide Accessories...
Request Info...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Biology Products: